
Anxiety and addiction treatment at Bliss Recovery addresses both conditions together, in one clinical plan, so neither keeps fueling the other. Here at Bliss Recovery, care runs from medical detox through residential, PHP, and IOP in a private Hollywood Hills residence, with one clinical team from intake through aftercare.
At a glance

Anxiety disorders and substance use disorders are among the most commonly co-occurring conditions in clinical practice. Each condition tends to worsen the other — substances are frequently used to manage anxiety symptoms, while sustained substance use worsens the underlying condition and makes recovery harder. Anxiety also commonly co-occurs with depression and PTSD — overlapping conditions that share many triggers and often require coordinated treatment.
Treating only the addiction leaves the most powerful driver of substance use unaddressed. That's why we treat anxiety as part of our wider approach to co-occurring disorders, addressing both conditions within one unified clinical plan rather than in isolation.
Anxiety disorders are the most common mental health conditions in the United States. According to the National Institute of Mental Health (NIMH), approximately 31 percent of U.S. adults will experience an anxiety disorder at some point in their lives, with about 19 million Americans meeting diagnostic criteria in any given year. The Anxiety and Depression Association of America (ADAA) estimates that anxiety disorders affect 40 million adults annually — a prevalence that makes them one of the most frequently co-occurring conditions alongside substance use disorders.
Research published by the Substance Abuse and Mental Health Services Administration (SAMHSA) and the National Institute on Drug Abuse (NIDA) shows that individuals with anxiety disorders are roughly twice as likely to develop a substance use disorder as the general population — and the reverse is equally true. Studies from Harvard Medical School and the National Comorbidity Survey Replication have documented that anxiety and substance use disorders share overlapping neurobiological pathways involving the amygdala, prefrontal cortex, and the brain's stress-response systems, making the two conditions deeply intertwined at a physiological level.
The self-medication hypothesis — extensively studied by Dr. Edward Khantzian at Harvard Medical School — offers a well-supported clinical framework: people with undiagnosed or undertreated anxiety frequently turn to alcohol, benzodiazepines, cannabis, and opioids to blunt anxious arousal. Over time, the substance use itself dysregulates the very anxiety systems it was meant to calm, driving both conditions deeper. Research from the National Institute on Drug Abuse supports treating co-occurring conditions at the same time rather than separately, which is why we address anxiety and addiction within the same clinical plan.
Racing heart, sweating, trembling, muscle tension, and sleep disturbances that intensify during withdrawal.
Excessive worry, restlessness, difficulty concentrating, and irritability that often precede substance use.
Avoidance, isolation, and compulsive substance use as self-medication — creating a cycle that deepens both conditions.
Anxiety spikes sharply during withdrawal from alcohol and benzodiazepines. Distinguishing withdrawal-driven anxiety from underlying anxiety disorder requires clinical assessment after stabilization.
Our admissions team is available around the clock — confidentially, and without pressure.
Treatment can begin in our residential program, where therapy, psychiatric support, and medication management run under one plan.
Systematic desensitization that reduces anxiety triggers without relying on substances, building confidence in managing discomfort.
SSRIs, SNRIs, and buspirone can help manage anxiety without the dependence risk of benzodiazepines.
Body-based techniques that calm the nervous system directly — breathwork, progressive relaxation, and mindfulness practices.
Anxiety changes the pace of treatment, so the continuum matters more here than it does for substance use alone. Clients move down as they stabilize rather than on a fixed schedule.
"Anxiety and addiction feed each other. Break the cycle by treating both at once — not one after the other."

A thorough evaluation distinguishes primary anxiety disorder from withdrawal-driven anxiety — a critical distinction that shapes the entire treatment plan. Medical stabilization addresses the physical symptoms that spike during early recovery.

CBT, gradual exposure, and somatic regulation techniques build non-pharmaceutical tools for managing anxiety. Individual and group sessions run in parallel, giving clients multiple pathways to practice new coping strategies.

Anxiety and addiction feed each other. SSRIs, SNRIs, and buspirone treat anxiety without the dependence risk of benzodiazepines — all coordinated with recovery goals within a single unified clinical plan.

Recovery extends beyond discharge. Our step-down PHP/IOP programming and alumni community keep clients connected, accountable, and supported during the months and years that follow residential treatment.

You don't have to face anxiety and addiction alone. Our team of compassionate clinicians is available around the clock, confidentially and without pressure, to help you plan your next steps.
Yes, it's common. Anxiety-like symptoms can climb during alcohol withdrawal and early abstinence, even in people without an anxiety disorder. That's why we wait until after medical stabilization to assess whether anxiety is withdrawal-driven or an underlying condition that needs its own treatment plan.
Often, yes. Our psychiatric team may consider non-benzodiazepine options such as SSRIs, SNRIs, or buspirone alongside therapy and body-based regulation techniques. Every medication decision is individualized and made by our medical team after a full assessment.
We build one plan that covers both. Therapy, psychiatric support, and medication management run in parallel, so you practice coping skills for anxiety while recovery from substance use is underway, with the same clinical team guiding each step.
It depends on your needs. Our residential program offers live-in care with daily therapy and psychiatric support, which can help when anxiety and substance use feel hard to manage at home. Some clients start in PHP or IOP instead, and an assessment helps decide what fits.
There's no fixed timeline. Detox typically runs five to ten days, and residential care often ranges from 30 to 90 days, with PHP, IOP, and aftercare following as you stabilize. Your clinical team adjusts the pace based on how you're doing.
Coverage depends on your plan. We work with most major PPO plans and are in-network with HealthSmart, MultiPlan, PMCS, and TriWest. You can verify your insurance at no cost before making any commitment.
Co-occurring disorders reinforce each other. We treat both simultaneously — with psychiatric support, therapy, and medication management.